Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal-Reference-Cited by-同舟云学术

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

Published:2003-05 Issue:7 Volume:17 Page:1017-1022
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Landman Roland,Schiemann Ricarda,Thiam Safiatou,Vray Muriel,Canestri Anna,Mboup Souleymane,Kane Coumba Toure,Delaporte Eric,Sow Papa Salif,Faye Mame Awa,Gueye Mandoumbe,Peytavin Gilles,Dalban Cecile,Girard Pierre-Marie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference13 articles.

1. Sequence Note: Identification of All HIV Type 1 Group M Subtypes in Senegal, a Country with Low and Stable Seroprevalence

2. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

3. Didanosine Dosed Once Daily Is Equivalent to Twice Daily Dosing for Patients on Double or Triple Combination Antiretroviral Therapy

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial;BioMed Research International;2018-12-25

2. Risk of Virological Failure and Drug Resistance During First and Second-Line Antiretroviral Therapy in a 10-Year Cohort in Senegal;JAIDS Journal of Acquired Immune Deficiency Syndromes;2013-04-01

3. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients;AIDS;2013-03-13

4. Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial;Antiviral Therapy;2013

5. Short-Term Virological Efficacy, Immune Reconstitution, Tolerance, and Adherence of Once-Daily Dosing of Didanosine, Lamivudine, and Efavirenz in HIV-1–Infected African Children: ANRS 12103 Burkiname;JAIDS Journal of Acquired Immune Deficiency Syndromes;2011-07-01